Podcasts about nhs

Some people have found themselves unable to get out and about due to heavy snowfall this week. Rachel meets Cameron Black based in Inverurie in Aberdeenshire who has been voluntarily clearing streets with his own plough.Scotland's Charity Air Ambulance has unveiled the most advanced helicopter air ambulance of its type in the UK, which operates from a base in Aberdeen. The new helicopter offers greater range and night vision technology. Mark heads to Dyce to chat to the crew.Community Off-Road Transport Action Group is a group of volunteers in 4x4s who have been helping to deliver medication and get NHS staff to work in the snowy conditions. Rachel joins volunteer Calum Auld to learn how the group have been helping those most in need in the Northeast of Scotland.Birds don't have access to the same quantities of food and water in the wintery weather. Mark and Rachel are joined by Richard Humpidge, Site Manager at RSPB Loch of Strathbeg nature reserve in Aberdeenshire, to discuss what we can do to help garden birds at this time of year.Rachel is in Govanhill in Glasgow to discover how new project Creative Canopies is aiming to create a dispersed orchard. Rachel meets Simone Stewart from Govanhill Baths Community Trust who explains how the project contributes to tree equity.In this week's podcast excerpt, Mark sketches old trees in Haddo Country Park, Aberdeenshire with artist Tansy Lee Moir.Fiona MacBaine from Inverness is known online as Fiona In The Wild where she documents her solo wild camping adventures. Phil Sime and Morven Livingstone wrap up to track Fiona down on the banks of Loch Ness.Mark takes a wander through his local area to contemplate the wintery scene and the potential impacts on people and wildlife. 4Status:

This week, the UK begins the rollout of the chickenpox vaccine to younger children. But why is it only being offered now? Plus, the high-level technological plan to capture Venezuela's Nicolás Maduro, what the latest research says about the health of vegan and vegetarian diets in the young, and the risks posed by "space junk" that falls back to Earth... Like this podcast? Please help us by supporting the Naked Scientists

This week, the UK begins the rollout of the chickenpox vaccine to younger children. But why is it only being offered now? Plus, the high-level technological plan to capture Venezuela's Nicolás Maduro, what the latest research says about the health of vegan and vegetarian diets in the young, and the risks posed by "space junk" that falls back to Earth... Like this podcast? Please help us by supporting the Naked Scientists

After I was paralysed in a climbing accident, I discovered how inconsiderate, illogical and incompetent many wheelchair providers can be By Paul Sagar. Read by Felipe Pacheco. Help support our independent journalism at theguardian.com/longreadpod

This week we take a look at the year ahead and make some predictions - including immigration, foreign doctors in the NHS; Islamisation - Mamdani, cancelling New Year celebrations, Brigitte Bardot;  Wars - Ukraine, Gaza, Venezuela, Cambodia, Thailand, Japan, China, India, Pakistan, Sudan; Euthanasia - in the UK and Canada;  Iran; Keir Starmer and Albo;  Social Media - Djokovic; The AI bubble;  Woke - Trans police in WA, Gabriel Jesus; Christian Growth;  the Final Word with music from Robert Plant, Deep Purple, Steely Dan, Blue Oyster Cult, and P.O.D

What kind of state does the UK find itself in as we start 2026? That's the question Tim Harford and the More or Less team is trying to answer in a series of five special programmes.In the third episode, we're searching for answers to these questions:Are there really 700,000 empty homes that could be used to solve the housing crisis?Does the NHS pay less for drugs than health services in other countries?Is violent crime going up or down?Is the UK in the midst of a fertility crisis?Get in touch if you've seen a number in the news you think we should take a look at: moreorless@bbc.co.ukContributors:Dr Huseyin Naci, Associate Professor and Director the Pharmaceutical Policy Lab at the London School of Economics Professor Jennifer Dowd, deputy director of the Leverhulme Centre for Demographic Science at the University of OxfordCredits:Presenter: Tim Harford Reporters: Lizzy McNeill and Nathan Gower Producers: Katie Solleveld and Charlotte McDonald Series producer: Tom Colls Production co-ordinator: Maria Ogundele Sound mix: Sarah Hockley and James Beard Editor: Richard Vadon

What kind of state does the UK find itself in as we start 2026? That's the question Tim Harford and the More or Less team is trying to answer in a series of five special programmes.In the second episode, we're asking some interesting questions about health and the NHS:Has life expectancy in the UK starting to go up again at last?What statistics tell you about the health of the NHS?After years of promises, are there actually any more GPs?What's happening to cancer rates in the UK?What's gone wrong with productivity in the health service?Get in touch if you've seen a number in the news you think we should take a look at: moreorless@bbc.co.ukContributors:Stuart McDonald, Head of Longevity and Demographic Insights at the consultancy Lane Clark & Peacock (LCP) Jon Shelton, Head of Cancer Intelligence at Cancer Research UK Ben Zaranko, Associate Director of the Institute for Fiscal StudiesCredits:Presenter: Tim Harford Reporter: Nathan Gower Producers: Lizzy McNeill, Katie Solleveld and Charlotte McDonald Series producer: Tom Colls Production co-ordinator: Maria Ogundele Sound mix: Sarah Hockley and Neil Churchill Editor: Richard Vadon

Currently, as of today's date, neither the ACOG nor SMFM currently support routine early induction of labor for suspected fetal macrosomia, instead recommending individualized counseling and reserving elective cesarean for extreme estimated fetal weights. However, a 2025 multicenter, open-label, randomized controlled trial was published in the Lancet comparing induction of labor versus standard care in pregnant women with fetuses suspected to be large for gestational age. The study used a parallel-group design with 1:1 randomization, enrolling women from 106 NHS hospitals across England, Scotland, and Wales. The per-protocol analysis demonstrated a significant reduction (40%) in shoulder dystocia with induction of labor at 38- 38 weeks and 4 days. Is this in conflict with the ACOG current guidance? In this episode, we will review the “Big Baby study” from the Lancet and provide 3 main limitations of this very large study, review the importance of PP vs ITT results, and explain why more data is still needed. Listen in for details. 1. ACOG PB 178; 2017 (reaffirmed 2024)2. Gardosi J, Ewington LJ, Booth K, Bick D, Bouliotis G, Butler E, Deshpande S, Ellson H, Fisher J, Gornall A, Lall R, Mistry H, Naghdi S, Petrou S, Slowther AM, Wood S, Underwood M, Quenby S. Induction of labour versus standard care to prevent shoulder dystocia in fetuses suspected to be large for gestational age in the UK (the Big Baby trial): a multicentre, open-label, randomised controlled trial. Lancet. 2025 May 17;405(10491):1743-1756. doi: 10.1016/S0140-6736(25)00162-X. Epub 2025 May 1. PMID: 40319899.3. Blaauwgeers, Anne N et al. Rethinking induction of labour for LGA fetuses: the Big Baby trial. The Lancet, Volume 406, Issue 10512, 1562

Kate Howard, CHE Pro Manager at the Centre for Homeopathic Education, joins us in this episode to share her personal journey into homeopathy, including how grief, anxiety, and health challenges during the COVID-19 pandemic led her to discover remedies like aconite for herself and her family. Kate talks about her training, building her practice, and the resources and community offered through CHE Pro, and she also gives a preview of the upcoming Elevate conference, which aims to support homeopaths both professionally and personally Episode Highlights: 03:24 - First encounter with homeopathy that changed everything 07:37 - Within 30 seconds, it stopped 11:58 - Overview of CHE Pro 18:42 - Upcoming CHE Pro Events 22:45 - Richard Pitt's Upcoming Series 25:31 - Dr Brian Kaplan's Webinar Series 27:48 - Jerry Vandenbosch's In-Depth Series 29:41 - CHE Pro Membership Updates 33:42 - Elevate Conference Announcement 38:01 - Kate's Clinical Practice 40:25 - Upcoming Beginner's Course with Marcus About my Guests: Kate Howard is a registered homeopath (RSHom) with the Society of Homeopaths, dedicated to supporting individuals and families in restoring health and wellbeing. She trained and practiced as a nurse within the NHS, gaining extensive experience in acute and chronic care, and witnessing firsthand the profound impact of illness on patients' lives. Kate discovered homeopathy during a personally challenging period as a mother of three, following the birth of her youngest child and the sudden loss of two close family members. Inspired by her own healing, she trained in classical homeopathy under the mentorship of an experienced practitioner and now practices alongside her mentor, combining her clinical expertise with holistic care. Kate is also trained in breastfeeding support and antenatal education, providing informed, compassionate guidance to mothers and families. Find out more about Kate Website: https://www.katehowardhomeopathy.com/ CHE Pro Elevate Waitlist https://cheonline.activehosted.com/f/61 CHE Pro Membership Waitlist https://cheonline.activehosted.com/f/59 Free Webinar with Richard Pitt https://chehomeopathy.com/lp-richard-pitt-webinar/ To know more about the Center for Homeopathic Education https://chehomeopathy.com/ If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode. Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/ Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom

Since her big break in Muriel's Wedding 30 years ago, actor Toni Collette has graced our screens in a huge list of standout roles from The Sixth Sense to Hereditary, Little Miss Sunshine to Mickey 17. She joined Kylie Pentelow to discuss her latest film, Goodbye June. The emotional directorial debut from Kate Winslet tackles themes of love, loss and Christmas as a fractious family come together to sit vigil for the family matriarch, played by Helen Mirren.From the very beginning of the NHS in 1948, Irish women were actively recruited to staff British hospitals. By the 1960s, there were around 30,000 Irish-born nurses - making up roughly one in eight of all nurses – yet their contribution has often gone unrecognised. A new book aims to change that. Based on dozens of interviews, it tells the story of Irish nurses in their own words. We hear from co-author of Irish Nurses in the NHS: An Oral History, Professor Louise Ryan, who spent years researching Irish migration and from Ethel Corduff, who came to England to train as a nurse, a career she spent 40 years in.Relative Energy Deficiency in Sport, or RED-S as it's known, was once framed as a concern only for elite athletes. But as running culture intensifies alongside weight-loss jabs and healthy eating trends, RED-S has become more widespread. It's often hard to spot, but the long-term consequences can be devastating, impacting immune function, growth and fertility. Sports dietitian Renee McGregor and Jodie Pearlman, who experienced the condition first hand, joined Kylie to talk about the condition.Why can adults seem to regress to childhood or teenage behaviours at Christmas? We discuss family dynamics and the kinds of behaviour that can re-surface with everyone under the same roof again. Guardian columnist Elle Hunt shares her own experience alongside Woman's Hour listeners, and psychotherapist Julia Samuel offers advice.It's 75 years since The Archers first launched. Woman's Hour broadcast from Ambridge to celebrate the female characters who have helped this programme tackle some of the most challenging, contentious and sensitive issues affecting women. Nuala McGovern joined Felicity Finch, who plays Ruth Archer, for a behind-the-scenes tour, along with Technical Producer Vanessa Nuttall.Presenter: Kylie Pentelow Producer: Annette Wells

Morse code transcription: vvv vvv Bristol dentists gave patients ultimatum before NHS sign up Trump says health is perfect amid ageing concerns Why everything from your phone to your PC may get pricier in 2026 From Harry Potter to Doctor Who new pictures show stars before they were famous UK weather Travel disruption expected as ice and snow grip UK The life and legacy of snooker hero and Masters champ Paul Hunter Harry Potter stunt double Breaking my neck hasnt changed me FTSE 100 index hits 10,000 milestone in new year rally Should the NHS use magic mushrooms to treat mental health Two charged after elderly man killed in Gillingham hit and run

Happy New Year Pandalorians! In the first part of this two part retrospective, Satsu is joined by the marvellous Marie from the WeNeededRoads podcast to discuss the positive impacts of AI in the world. How has AI helped with wildlife conservation? Can charities and health services such as the NHS truly benefit from its usage? And how has it helped the hosts in day to day life? Without any further ado, let's find out!This podcast is a member of the PodPack Collective, an indie podcasting group dedicated to spreading positivity within the podcast community. For further information, please follow the link: https://linktr.ee/podpackcollectiveCheck out all of our content here: https://linktr.ee/chatsunamiWebsite: chatsunami.comTwitter/X: https://twitter.com/ChatsunamiPodInstagram: https://www.instagram.com/chatsunami/TikTok: tiktok.com/@chatsunamiPatrons:Super Pandalorian Tier: Battle Toaster Ghostie Cryptic1991Red Panda Tier: Greenshield95 Danny Brown Aaron HuggettFree Members: Middle-aged Bodcast Rob Harvey Aaron (Super Pod Saga) Billy Strachan SoniaUse my special link zen.ai/chatsunami and use chatsunami to save 30% off your first three months of Zencastr professional. #madeonzencastrCreate your podcast today! #madeonzencastrStay safe, stay awesome and most importantly, stay hydrated!

In this episode, orthodontist Zaid Esmail opens up about what really matters in patient care—and it's not just straight teeth. From calling every patient the week after fitting braces to navigating the tension between NHS pragmatism and private practice perfectionism, Zaid reveals why communication trumps technique every time. He shares the terrifying moment a patient swallowed a spring mid-treatment, the legal nightmare of inventing an orthodontic device, and why he built an online academy to teach GDPs the skills they're inevitably going to use anyway. Plus, there's an honest take on conference culture, overtreatment trends, and why he refuses to become the kind of orthodontist who needs cases to pay bills. Want 10% off Zaid's Online Orthodontic Academy course and mentorship? Use code DLPOD10 at https://onlineorthodonticacademy.co.uk/In This Episode00:01:20 - What makes a great orthodontist 00:06:25 - Why he'll never own a fully private practice 00:14:40 - From Iraq to Wales via dental school 00:28:00 - Teaching philosophy and the dangers of weekend courses 00:37:50 - Where GDPs go wrong with orthodontics 00:41:45 - Building the Online Orthodontic Academy 00:52:50 - Blackbox thinking 00:58:05 - Inventing the Eruptor device 01:16:45 - Conference culture and the problem with celebrity orthodontists 01:24:10 - Fantasy dinner party 01:27:10 - Last days and legacyAbout Zaid EsmailZaid Esmail is an orthodontist working at Grosvenor House Orthodontic Practice in Tunbridge Wells, part of the Bupa Dental Care group. He runs the Online Orthodontic Academy, providing diploma-level training and case mentorship for dentists looking to incorporate orthodontics into their practice. Zaid also invented the Eruptor, a device for managing partially erupted teeth. Follow him on Instagram at @onlineorthoacademy and @zaid_mails.

In this special end-of-year episode of Behind the Genes, host Sharon Jones is joined by Dr Rich Scott, Chief Executive Officer of Genomics England, to reflect on the past year at Genomics England, and to look ahead to what the future holds.  Together, they revisit standout conversations from across the year, exploring how genomics is increasingly embedded in national health strategy, from the NHS 10-Year Health Plan to the government's ambitions for the UK life sciences sector. Rich reflects on the real-world impact of research, including thousands of diagnoses returned to the NHS, progress in cancer and rare condition research, and the growing momentum of the Generation Study, which is exploring whether whole genome sequencing could be offered routinely at birth.  This episode offers a thoughtful reflection on how partnership, innovation, and public trust are shaping the future of genomic healthcare in the UK and why the years ahead promise to be even more exciting.  Below are the links to the podcasts mentioned in this episode, in order of appearance:  How are families and hospitals bringing the Generation Study to life? How can cross-sector collaborations drive responsible use of AI for genomic innovation? How can we enable ethical and inclusive research to thrive? How can parental insights transform care for rare genetic conditions? How can we unlock the potential of large-scale health datasets? Can patient collaboration shape the future of therapies for rare conditions? https://www.genomicsengland.co.uk/podcasts/what-can-we-learn-from-the-generation-study “There is this view set out there where as many as half of all health interactions by 2035 could be informed by genomics or other similar advanced analytics, and we think that is a really ambitious challenge, but also a really exciting one.”  You can download the transcript, or read it below. Sharon: Hello, and welcome to Behind the Genes.   Rich: This is about improving health outcomes, but it's also part of a broader benefit to the country because the UK is recognised already as a great place from a genomics perspective. We think playing our role in that won't just bring the health benefits, it also will secure the country's position as the best place in the world to discover, prove, and where proven roll out benefit from genomic innovations and we think it's so exciting to be part of that team effort.  Sharon: I'm Sharon Jones, and today I'll be joined by Rich Scott, Chief Executive Officer at Genomics England for this end of year special. We'll be reflecting on some of the conversations from this year's episodes, and Rich will be sharing his insights and thoughts for the year ahead. If you enjoyed this episode, we'd love your support, so please subscribe, rate, and share on your favourite podcast app. So, let's get started.  Thanks for joining me today, Rich. How are you?  Rich: Great, it's really good to be here.   Sharon: It's been a really exciting year for Genomics England. Can you tell us a bit about what's going on?  Rich: Yeah, it's been a really busy year, and we'll dive into a few bits of the components we've been working on really hard. One really big theme for us is it's been really fantastic to see genomics at the heart of the government's thinking. As we'll hear later, genomics is at the centre of the new NHS 10-year health plan, and the government's life sciences sector plan is really ambitious in terms of thinking about how genomics could play a role in routine everyday support of healthcare for many people across the population in the future and it shows a real continued commitment to support the building of the right infrastructure, generating the right evidence to inform that, and to do that in dialogue with the public and patients, and it's great to see us as a key part of that.  It's also been a really great year as we've been getting on with the various programmes that we've got, so our continued support of the NHS and our work with researchers accessing the National Genomic Research Library. It's so wonderful to see the continued stream of diagnoses and actionable findings going back to the NHS. It's been a really exciting year in terms of research, publications. In cancer, some really exciting publications on, for example, breast cancer and clinical trials. Really good partnership work with some industry partners, really supporting their work. For me, one of the figures we are always really pleased to see go up with time is the number of diagnoses that we can return thanks to research that's ongoing in the research library, so now we've just passed 5,000 diagnostic discoveries having gone back to the NHS, it really helps explain for me how working both with clinical care and with research and linking them really comes to life and why it's so vital.   And then, with our programmes, it's been great to see the Generation Study making good progress. So, working with people across the country, more than 25,000 families now recruited to the study, and we're beginning to hear about their experiences, including some of the families who've received findings from the programme. It's really nice to see and hear from Freddie's family, who talked to the press a bit about the finding that they received. Freddie was at increased risk of a rare eye cancer, and really pleasingly, it was possible to detect that early through the screening that was put in place. Again, it really brings to life why we're doing this, to make a difference and improve health outcomes.  Sharon: That's an incredible 12 months. Diving into that Generation Study piece and for listeners who don't know what that is, it's a research study in partnership with the NHS that aims to sequence the genomes of 100,000 newborn babies. On an episode from earlier in the year, we had mum, Rachel Peck, join the conversation, whose baby Amber is enrolled on a study. Let's year from Rachel now.  Rachel: From the parents' point of view, I guess that's the hardest thing to consent for in terms of you having to make a decision on behalf of your unborn child. But I think why we thought that was worthwhile was that could potentially benefit Amber personally herself or if not, there's the potential it could benefit other children.  Sharon: Consent has been such a big area of focus for us, Rich, and Rachel touches on that complexity, you know, making a decision on behalf of her unborn child. Can you talk a bit about our approach to consent in the Generation Study and what's evolving in that model?  Rich: Yeah. It's been for the whole study, really, starting out asking a really big question here, what we're aiming to do is generate evidence on whether and if so, how whole genome sequencing should be offered routinely at birth, and that's responding to a really ill need that we know that each year thousands of babies are born in the UK with treatable rare conditions. We will also need to see if whole genome sequencing can make a difference for those families, but we realise to do that, as with all screening, that involves testing more people than are going to benefit from it directly themselves. So, you have to approach it really sensitively. There's lots of complicated questions, lots of nuance in the study overall. One of them is thinking really carefully about that consent process so that families can understand the choices, they can understand the benefits and risks. This is still a research study. We're looking to understand whether we should offer this routinely. It's not part of routine care at this point. The evidence will help decision-makers, policymakers in the future decide that.  At the beginning of the programme, we spent a lot of time talking to families, talking to health professionals who understand the sorts of decisions that people are making at that time of life, but also are experts in helping think about how you balance that communication. That involved, as I say, a lot of conversations. We learnt a lot, lots of it practical stuff, about the stage of pregnancy that people are at when we first talk to them about the study, so that people aren't hurried and make this decision. What we've learnt in the study, right from the outset, is talking to people from midway through the pregnancy so that they really have time to engage in it and think about their choice. So, it's an important part of getting the study design right so that we run the study right. It's also a really crucial element of the evidence that will generate from the study so that we can understand if this is something that's adopted, how should we communicate about it to families. What would they want to know? What's the right level of information and how do we make that accessible in a way that is meaningful to people from different backgrounds, with different levels of interest, different accessibility in terms of digital and reading and so on. There's a lot that we've learnt along the way and there's a lot that we're still learning. And as I say, important things that we'll present as evidence later on.  Sharon: Thank you. It's fascinating there are so many moving parts and a lot to consider when you're building the design of a programme like this or study like this.  Earlier in the year you had a great conversation with Karim Beguir about the developments of AI in genomics. Let's revisit that moment.  Karim: We live in an extraordinary time. I want to emphasise the potential of scientific discovery in the next two or three years. AI is going to move, let's say, digital style technologies like coding and math towards more like science and biology. In particular, genomics is going to be a fascinating area in terms of potential.  Sharon: So, Karim talks about AI moving from maths and coding into biology. Why is genomics such a natural area for AI?  Rich: It's really fascinating. I think it links a lot to how we think about genomics and how you get the most value in terms of health benefit and sort of the progress that we can see could come through genomics more generally. So, your genome, which is your DNA code, written in 3 billion little letters across each one of us, one copied from mum, one copied from dad, even just our genomic code of one person is a large amount of data. That is just part of the story because we're not just interested in DNA for DNA's sake, this is about thinking about health and how we can improve health outcomes. So, it's also thinking about the other sorts of information that needs to link to genomic data to make a difference. Whether that's just to provide routine healthcare with today's knowledge, or whether it's about continuing to learn and discover.  As I mentioned at the beginning, I think a really important part of this whole picture is we've learnt a lot in the last 20/30/40 plus years about genomics. It's incredible how much progress has been made, and we're really just scratching the surface. Take rare disease and the progress that's been made there, it's wonderful how many more families we're able to help today. We know that many thousands of families we still can't find a diagnosis for when we know that there is one there for many of them. That theme of ongoing learning is at the centre of all of our work, and that will continue as we look about broader uses of genomics in other settings beyond rare conditions and cancer. It's also that ongoing learning, but also the amount of, at the moment, manual steps that are required in some of the processes that we need to, for example, find a diagnosis for someone or to make sure the tools that we use are the most up to date, the most up to date with the medical literature, for example. AI is a tool that we're, as the whole of the society, we're beginning to see how it can play a role. We see it as important today for some of the just really practical things. I mentioned it, staying up to date with the medical literature, making sure that we and our systems are aware of all of the knowledge that's coming in from around the world. It's got real potential there.  I think the biggest bottom line here is that it's got the potential to be a really important tool in terms of our ongoing learning and improvement. I'm a doctor by background, the human intelligence alone is fantastic, it's moved us a long way, but we know it also has tremendous blind spots. AI has the potential to complement us there. I guess another thing to really call out here, AI isn't a panacea, it's not suddenly going to answer all of the questions. And, just like human intelligence, it will have its own biases, have its own strong points, and less strong points.  One of the things we're really committed to is working with people like Karim, and many others, to understand where AI could make a difference, to test it, to generate evidence on how well it works and an understanding in all sorts of ways about how that might play out. And, make sure that as AI becomes a tool, that we in genomics, but also in other areas, we understand its strong points and where we need to be more careful and cautious with it. That's a really important part of what we're going to be doing in the coming years here, is making sure that we can maximise the impact of it, but also be confident, so that we can explain to people whose data we might use it on how we're doing it and what it's bringing.  Sharon: Thanks Rich. It's definitely a fast-moving conversation of which we really want to be part of. One of the things that's come up again and again this year is participation and co-production. Let's hear quote that really captures that.  Bobbie: In an earlier conversation with Paul, which you might find surprising that it's stuck with me so much, he used the word ‘extractive'. He said that he'd been involved in research before and looking back on it, he had felt at times it could be a little bit extractive. You come in, you ask questions, you take the data away and analyse it, and it might only be by chance that the participants ever know what became of things next. One of the real principles of this project was always going to be co-production and true collaboration with our participants.  Sharon: That was Professor Bobbie Farsides talking about moving away from extractive research towards true co-production. How are we making that shift in practice here at Genomics England?  Rich: It's a great question. It's one of the areas where I think we've learnt most as an organisation over the years about how really engaging from the beginning with potential participants in programmes, participants who join our programmes, people who are involved in delivering our programmes and healthcare is so important at the beginning. I mentioned earlier the work to think about the consent process for the Generation Study, and that's one of the areas where I think from our first programme, 100,000 Genomes Project, we learnt a lot about how to do that well, some of the pitfalls, some of the bits that are most challenging. And really, right from the start of our programmes, making sure that people who will potentially benefit from the programmes, potentially join them, can be part of that engagement process, and really part of the design and the shaping of the research questions, the parameters around research, but also the materials and how people will engage with them. And that's one of the key capabilities we have internally as an organisation, so we work with partners externally, but also it's a really key part of the team that we have at Genomics England.  Sharon: So, whilst Bobbie talked about moving away from research that can feel one-sided and towards true collaboration, in another episode, Lindsay, a parent of a child with a rare condition, reflected on what that change really means for families and how it's empowering to see their voices and experiences shaping future treatments.  Lindsay: Historically, there's been a significant absence of a patient voice in rare disease research and development. And knowing that that's changing, I think that's really empowering for families. To know that professionals and industry are actually listening to our stories and our needs and really trying to understand, that offers much greater impact on the care and treatments of patients in the future.  Sharon: So, what role do you see participants as partners in shaping the next phase of Genomics England's work?  Rich: So, as you probably detected from my last answer, we see it as absolutely vital. One of the really exciting things here at Genomics England, we've had a participant panel from very early in our life as an organisation. That's one really important route to us at the heart of our organisation, part of our governance, making sure that participants representing all sorts of parts of our programme, but rare conditions being a really large focus for us. And I think, what's so striking as someone with a medical and a research background can see how I think historically medics and researchers have sometimes not known, sort of maybe been a bit scared about knowing how to involve participants from the outset. Often, because they're worried that they might ask the wrong questions in the wrong way, they just don't have the tools.   One of the things I often say now to people we work with is one of the most empowering and positive experiences we have at Genomics England is the power of our participants helping to, right from the beginning, shape what the questions are that we should be asking. Realise some of the challenges that you can't possibly, if you're not in their shoes, understand are the most important to really shape how we prioritise our work internally, the problems that we need to solve first, how we think about some of the practical impacts on people's lives that, again, without hearing from their voice you just wouldn't know. And again, to help our researchers, people accessing data in the National Genomic Research Library, helping them make sure that they involve participants in their work and the confidence and tools to do that.  Sharon: That's great, thank you. Another big theme this year has been collaboration across the NHS, academia, and industry. Dr Raghib Ali puts this really well.  Raghib: There are areas where academia and the NHS are very strong, and there are areas where industry is very strong, and why working together, as we saw, you know, very good examples during the pandemic with the vaccine and diagnostic tests, etc., a collaboration between the NHS, academia, and industry leads to much more rapid and wider benefits for our patients and, hopefully, in the future for the population as a whole in terms of early detection and prevention of disease.  Sharon: So, how does collaboration fit into the 10-year health plan and what's next for 2026 in that space, Rich?  Rich: I think one of the most enjoyable parts of my role at Genomics England and our role as an organisation is the fact that we see ourselves very much as part of a, sort of team across the UK and in fact internationally in terms of delivering on the potential we see for genomics. So, we have a vision as an organisation, which has been the same the last 5 or so years, which is a world where everyone can benefit from genomic healthcare. In fact, that vision is now shared by the NHS from a genomics perspective, and really demonstrably, the 2 parts of the system absolutely pointing in the same direction. And when we've been thinking, looking forward with that 10-year lens on it, what we always like to do, and I think it's a real privilege to be able to do, because we're here in the UK, because we have a National Health Service, because there's been that long-term commitment from government on genomics and really taking a long-term investment view there, and because of so many other parts of the ecosystem, other experts who access data in the National Genomic Research Library, research organisations like Our Future Health, UK Biobank, all teaming together, and the expertise that's there in genomics more broadly. So we've, if you like, worked back from what the UK could do as whole, and in the 10-year health plan, as I said earlier, genomics is at the heart of that.  There's a double helix on the front cover and, in fact, on the watermark on almost every page. And, there's this view set out there where as many as half of all health interactions by 2035 could be informed by genomics or other similar advanced analytics. And we think that that's a really ambitious challenge. We see a really important role for us, as Genomics England, in contributing to that, but it's very much a team effort. Our role is around where we have the biggest capabilities, so around building and running digital infrastructure at a national scale for healthcare delivery and for research, to building evidence to inform future policies, so running programmes like the Generation Study to inform future policy. And really, as part of that, that evidence piece, being driven by engagement, ethics, and work on equity, to really make sure that evidence that future policy can be built on is informed by a fully rounded view. We think if we do that right that we could as a country with others, the NHS, research organisations, many others could live up to that ambition that's set out there in the 10-year plan.   And the 10-year plan is really clear, and government is really clear that this is about improving health outcomes. But it's also part of a broader benefit to the country because the UK is recognised already as a great place from a genomics perspective. We think playing our role in that won't just bring the health benefits, it also will secure the country's position as the best place in the world to discover, prove and where proven role out benefit from genomic innovations. And we think it's so exciting to be part of that team effort.  Sharon: So, Genomics England's refreshed mission and direction of travel is really setting out how we move from research to routine care, and how we embed genomics across the health system. Carlo Rinaldi captured the idea perfectly, imagining a future where diagnosis and hope arrive hand in hand.  Carlo: My dream is that in five to ten years' time an individual with a rare disease is identified in the clinic, perhaps even before symptoms have manifested. At that exact time the day of the diagnosis becomes also a day of hope, in a way, where immediately the researcher, the genetic labs, flags that specific variant, that specific mutation. We know exactly which is the best genetic therapy to go after.   Sharon: And Rich, what are your thoughts on that?  Rich: I think Carlo captures it really well. And for us, I think a really big theme is for that potential for genomics to make a difference, a continued and in fact increased difference for people with rare conditions and cancer, areas where it's already making a difference, but also with the potential to make a much broader impact for people across the population. The real theme is embedding genomics into routine care, making it something that you don't need to know that you're seeing an expert in genomics to benefit from it, really make sure that those benefits can be felt as just part of routine care. It's not something separate where we recognise that the best healthcare is healthcare that's supported by all sorts of inputs, with genomics being a key part of that, and that we can continue to learn as we do that. So that with people's consent, with their understanding of how their data is being used, we know that if we don't have the best answer for them today, we give the best answer we can today, and we can continue to learn, and they can benefit from that in the future.   I'm a rare disease doctor by background, and one of the really most enjoyable parts of my job is seeing that come to practice. In the last year or so I've had a number of families where I've been seeing the family for years, and a researcher accessing data in the National Genomic Research library has found an answer that we've not been able to find for maybe their child's whole life, and then finally we're able to feed it back. Seeing that come to life is just so wonderful, and I think gives us a bit of a blueprint for how things could work more generally.  Sharon: That's great. I mean, what a feeling for those families who do get those answers. As we look ahead to 2026 and beyond, the conversation is starting to include prevention, using genomics not just to diagnose conditions but to predict and treat and even prevent them. Alice Tuff-Lacey summarised this nicely in an episode about Generation Study.  Alice: This is quite an exciting shift in how we use whole genome sequencing, because what we're talking about is using it in a much more preventative way. Traditionally where we've been using it is diagnostically where we know someone's sick and they've got symptoms of rare condition, and we're looking to see what they might have. What we're actually talking about is screening babies from birth using their genome to see if they're at risk of a particular condition. And what this means is this raises quite a lot of complex ethical, operational, and scientific and clinical questions.  Sharon: Rich, when you think about 2026, what's your biggest hope for where we'll be this time next year?  Rich: I think it's a really exciting time. As you can tell from how we've been speaking, I'm really excited about the direction of travel and how over the next 5 and 10 years we can really make a transformational shift because of how well placed we are in the UK from a genomics perspective. Where we are with today's knowledge, where we could be because of the continued government and NHS commitment to genomics being at the heart of this, if we build the right infrastructure, if we generate the right evidence to inform what's adopted, I think we're in a really exciting place.  From a 2026 perspective, I think what we're really committed to is continuing to do the work, the day-by-day-by-day work that is to build that incrementally. So, a really big focus for us is continuing to support the NHS and making sure researchers can access data, so that flow of answers for families can continue and grow, accelerate, to continue delivering the Generation Study because it's a really important part of that wider jigsaw to generate the evidence that can inform future policy on whether this is something that's adopted and offered routinely to every child when they're born.  I think a really important time now that the government's provided the opportunity for us as a team, as a UK genomics and life sciences ecosystem, is to really put in place some of the next steps, the building blocks that can take us towards that 10-year vision. So for us also, a really important part of the year is beginning the design process for an adult population genomics programme, where we're looking at what evidence it's important that we can provide that's complementary to different work around by others in the ecosystem that needs to be there if we're going to think about that potential broader use of genomics.  Sharon: That's great. It sounds like another exciting year ahead. So, we're going to wrap up there. Thank you to Rich Scott for sharing your reflections on the key milestones this year, and for your thoughts on the year ahead. Thanks, Rich.  Rich: Thanks very much for having me.  Sharon: If you enjoyed today's episode, we'd love your support, so please subscribe, share, and rate us on wherever you listen to your podcasts. I've been your host, Sharon Jones. This podcast was produced by Deanna Barac and edited by Bill Griffin at Ventoux Digital. Thank you for listening. 

Over the holiday season, I'm releasing a couple of previous podcasts that were particularly popular with listeners. This first one is an interview I did with GP Dr David Unwin. David  has been a pioneer in the UK developing and promoting a low-carb approach for treating type 2 diabetes. In 2016, he won the NHS innovator of the year award for his work. His treatment approach has been so successful that  he has put around half his type 2 diabetic patients, who follow a low carb diet, into remission. And as a result, his practice, spends far less on diabetic medication than any of the surrounding GP surgeries. The potential cost savings if this approach was adopted nationally and internationally, would be huge for health services across the world. We tend to think that unless we have a form of diabetes that we don't really need to be concerned about our blood sugar levels, but nothing could be further from the truth. As we get older, all of us unless we change our diet and lifestyle, will see our blood sugar levels rise, this causes our bodies to produce more and more insulin, which can lead to insulin resistance. If we eat a diet high in carbohydrates, this is likely to exacerbate the problem. And that matters because insulin resistance isn't just linked to type 2 diabetes but a wide range of illnesses including high blood pressure, heart disease, Alzheimer's and some cancers too. In the podcast, David discusses the Public Health Collaboration, a charity that he set up with colleagues, which aims to promote metabolic health and so prevent many chronic diseases. Here's a link to it: https://phcuk.org/ And here is a link to David's most recent paper published in BMJ nutrition, also discussed in the podcast: https://nutrition.bmj.com/content/6/1/46   If you would like to support this podcast you can do so via Patreon at or via PayPal. The host of the podcast, Liz Tucker is an award winning medical journalist and former BBC producer and director.  You can follow Liz on Twitter at https://twitter.com/lizctucker and read her Substack newsletter about the podcast at https://liztucker.substack.com Medical Matters with Liz Tucker has been selected by Feedspot as one of the top 15 UK Medical Podcasts https://blog.feedspot.com/uk_medical_podcasts/

Alan Leer runs through the biggest science threads of 2025 — from world-first gene editing on the NHS and UK temperature records to Nobel-level physics and a rare interstellar visitorFor the latest news, visit Standard.co.uk Hosted on Acast. See acast.com/privacy for more information.

Rich Novak is a legendary figure in action sports, the co-founder of NHS, Inc. (home to Santa Cruz Skateboards, Independent Trucks, etc.) in 1973, and played a key role in creating Santa Cruz Bicycles, making him central to the iconic Santa Cruz surf and skate scene and its global brands. Known for his innovation, down-to-earth nature, and foundational role in shaping modern skateboarding and mountain biking, he's a true Santa Cruz icon.

A full NHS investigation is under way after Scotland's biggest hospital released the wrong body for a cremation. The mistake was made by mortuary staff at Queen Elizabeth University Hospital in Glasgow. They have been suspended. The error involved incorrect labelling. It emerged only after the funeral service and cremation had taken plac

The Chancellor announced dozens of changes in the Budget that will affect the money in your pocket from wages and energy bills to savings. Many of them won't happen for some time - years in some cases - so we look at the more imminent tax changes. That will include the freezing of tax thresholds that will see higher taxes for many and changes to the Cash ISA limits.A "bewildering system" of benefits - that's how the author of a new report has described the plight of tens of thousands of unpaid carers who were thrown into debt because of the overpayment of Carer's Allowance. This week an independent review was published that's been a year in the making. It started because carers had been working but had unwittingly slipped over the amount they're able to earn before losing their Carer's Allowance - a payment they're entitled to if they care for someone for over 35 hours a week, leaving them in debt to the government. Paul Lewis interviews the author of the report Liz Sayce, who has told Money Box the government must implement her recommendations "at pace".And, the families of thousands of people who were infected with HIV and Hepatitis C by the NHS when it used contaminated blood in the 1970s and 80s will not have to pay tax on the compensation many of them are still waiting for. That commitment came from Rachel Reeves in the Budget, after Money Box reported on a campaign to ensure those relatives weren't subject to inheritance tax bills of tens of even hundreds of thousands of pounds.Presenter: Paul Lewis Reporters: Dan Whitworth and Jo Krasner Researcher: Eimear Devlin Editor: Jess Quayle Senior News Editor: Sara Wadeson(First broadcast 12pm Saturday 29th November 2025)

What's possible for occupational therapists beyond burnout, rigid systems and traditional career paths? In this special compilation episode, host Beki Eakins brings together powerful conversations from across 2025, featuring occupational therapists from the UK, Australia, Canada and beyond who have created businesses, roles and lifestyles aligned with their values. You'll hear honest stories about leaving the NHS, navigating burnout, overcoming imposter syndrome, building online and private practice businesses, and redefining what success looks like as an OT. From paediatrics and dementia care to leadership, embodiment, social media and ethical business growth, these conversations highlight the depth, creativity and impact of occupational therapy worldwide. This episode is designed to inspire occupational therapists heading into 2026, whether you're curious about business, craving more flexibility, or simply wanting to reconnect with why you chose OT in the first place. In This Episode, You'll Hear About: • Creating freedom-based OT businesses • Burnout, boundaries and nervous system regulation • Online work, private practice and alternative models • Leadership, confidence and authenticity as an OT • Ethical income, impact and alignment • Global OT perspectives and shared professional values Connect with Beki Are you ready to leave the whinger mindset behind and embrace your inner go-getter? Beki helps OTs worldwide design, launch, and scale their online business Free Resource: Download Beki's free overnight mindset meditation for free to help you build confidence, overcome money mindset challenges, and develop self-belief. Join OT Yourself To Freedom Membership: Discover the only membership designed specifically for OTs to create freedom-based businesses by leveraging the skills you already have. Learn to design and sell offers, market effectively, and align your work with your purpose. nesses. Learn how to tap into your purpose and create an offer that sells with ease.. Follow Beki: Website: www.bekieakins.com Instagram: OT Yourself to Freedom Facebook Group: OT Freedom Community LinkedIn: Beki Eakins Book an Inspiration Call: Click here About the Podcast OT Yourself To Freedom Podcast helps occupational therapists create a life and business they love. Host Beki Eakins shares practical tips, strategies, and real-world stories to inspire your journey to freedom Love this episode? Subscribe to OT Yourself to Freedom and leave a review! Your feedback helps more OTs break free from burnout and build a business they love.

Check if your dental practice qualifies for capital allowances here >>> https://www.dentistswhoinvest.com/chris-lonergan———————————————————————UK Dentists: Collect your verifiable CPD for this episode here >>> https://courses.dentistswhoinvest.com/smart-money-members-club———————————————————————What if the fastest way to grow a dental practice is not a new scanner, but a new agreement? We sit down with Lisa, a former dental nurse who became a practice stakeholder, to unpack how equity, trust, and smart systems turn a busy clinic into a resilient, two-site business that serves patients better and performs stronger.Lisa shares the early lessons she took from running operations in a GP super centre: finance visibility, team training, and the simple truth that people remember how you make them feel. Those foundations shaped a strategy that moved a three-person team into a private-led model with an NHS arm ring-fenced in a nearby site for stability and optionality. We talk openly about when equity for a practice manager makes sense, why it should be a cherry not a carrot, and how small ownership stakes can unlock the discretionary effort owners quietly hope for but rarely earn.We dive deep on incentives that work—like sharing a slice of verified stock savings—and why owners who cling to cash starve growth. The numbers matter: monthly KPIs, white space costs, staffing ratios, and fee calibration can add six figures without longer clinical hours. And then there's the biggest lever of all: communication. Lisa breaks down the ten-second phrases that de-escalate complaints, the reception scripts that convert more enquiries into appropriate appointments, and how AI call reviews help front-of-house master tone, empathy, and listening.If you're an owner or manager who wants fuller diaries, fewer fire drills, and a team that thinks like partners, this conversation hands you the blueprint: align incentives, measure what matters, and coach the words that win trust. Subscribe, share this with your practice lead, and leave a review telling us one change you'll make this week.———————————————————————Disclaimer: All content on this channel is for education purposes only and does not constitute an investment recommendation or individual financial advice. For that, you should speak to a regulated, independent professional. The value of investments and the income from them can go down as well as up, so you may get back less than you invest. The views expressed on this channel may no longer be current. The information provided is not a personal recommendation for any particular investment. Tax treatment depends on individual circumstances and all tax rules may change in the future. If you are unsure about the suitability of an investment, you should speak to a regulated, independent professional. Investment figures quoted refer to simulated past performance and that past performance is not a reliable indicator of future results/performance.Send us a text

In this Christmas special Matt invites Act On This tv's Ross Grant and Lee Petcher, along with Success School's Helen Hill to sit down and have an open honest conversation. Sharing their experience, Matt, Helen, Ross and Petch talk about some of the lessons and highlights from this past year, what running a business has taught them about themselves plus much more.   Follow Matt Hall at:  Instagram: https://www.instagram.com/matthallofficial/   Follow Act On This tv at:  Instagram: https://www.instagram.com/actonthistv/?hl=en   Follow Helen Hill at: https://www.instagram.com/feartofabulousocd/   This episode is sponsored by Dr. Tania King-Mohammad - The High Ticket Woman, #1 bestselling author of The High Ticket Method, and one of the most sought-after high-ticket sales experts in the game. If you're listening right now, you already know you're built for more. So here's your next move: grab her book The High Ticket Method click here, then head to Instagram @freedomwithtania where she's dropping the kind of strategies and activations that will change the way you sell forever. Dr. Tania King-Mohammad - The High Ticket Woman and your go-to high-ticket sales expert. Go connect with her today, and thank me later.     This episode is also sponsored by Laura Robson and Back Pocket Office. Laura is a systems strategist and certified launch & funnel specialist who helps coaches, consultants and creators build business systems that give them more freedom. Laura is here to help sort all your tech and funnels for your so that you can focus on sales, marketing and delivering... and not have to stress about making sure the tech automations and systems are working. With over 14 years experience of workflow automation in the NHS and healthcare IT, she now brings that expertise to the online business world. Through Laura's signature Strategy–Build–Launch service, she can help you design and build the systems that keep your business running smoothly – from mapping out a clear customer journey to building the tech that supports it. Her approach is calm and collaborative – with a focus on creating beautifully simple systems that give you time back. So if tech has been the thing holding you back, Laura can help you build an online business that works for you. Find out more at www.backpocketoffice.co.uk or connect with Laura on the instagram here.  

Episode 149 - Digital health with a difference - Medefer are streamlining the slow parts of the NHS. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Dr Rachel Clarke is a palliative care doctor and author, who became widely known for her writing on the challenges facing the NHS from the frontline of the Covid-19 pandemic. Since then she has also written a book, The Story of a Heart which was awarded the 2025 Women's Prize for Non-Fiction which tells the profoundly moving story of a heart transplant, and how one child saved the life of another. In November 2025 Clarke came to Intelligence Squared alongside actor, comedian and writer Rob Delaney to discuss this unforgettable story and what it tells us about compassion, family, medical innovation and the future of the national health service. ---  If you'd like to become a Member and get access to all our full ad free conversations, plus all of our Members-only content, just visit intelligencesquared.com/membership to find out more. For £4.99 per month you'll also receive: - Full-length and ad-free Intelligence Squared episodes, wherever you get your podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series - 15% discount on livestreams and in-person tickets for all Intelligence Squared events  ...  Or Subscribe on Apple for £4.99: - Full-length and ad-free Intelligence Squared podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series … Already a subscriber? Thank you for supporting our mission to foster honest debate and compelling conversations! Visit intelligencesquared.com to explore all your benefits including ad-free podcasts, exclusive bonus content and early access. … Subscribe to our newsletter here to hear about our latest events, discounts and much more. https://www.intelligencesquared.com/newsletter-signup/ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Hey huns! Welcome back to another episode! We're so excited to kick off the year with our first guest episode, and it had to be family. You've definitely heard us mention her before! It's Jasmine's bestie, Lizzie! In this episode, Lizzie talks us through her journey to becoming a therapist, what it's really like working in the NHS, and she kindly shares some practical tips we can all take away. She also dives into her love for music and how she ended up becoming a DJ! Let us know what you think! You can also watch this episode on YouTube: https://youtu.be/nioGaM5x5Q0 Follow Lizzie on socials: IG: https://www.instagram.com/lizzierxse/ Soundcloud: https://soundcloud.com/amapianogirlie/private-school-mix-wav?ref=clipboard&p=i&c=1&si=6C844390276149AE8BE8CAB093332B7E&utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing TikTok: https://www.tiktok.com/@lizzierosedj --------------------------------------------------------------------------------------------------------------- Use VICJASCB for 10% off at ⁠https://www.currentbody.com/⁠ You can send dilemmas by using this link: https://bit.ly/3FzyTGG (If you'd like to listen to our episodes ad-free, please join our Patreon :) ) If you are thinking about getting therapy but not sure where to start, check out our sponsor www.betterhelp.com/BGL HOSTS:⠀ Jas: twitter.com/jas_bw + www.instagram.com/jas_bw/ Vic: https://www.tiktok.com/@vicsanusi + www.instagram.com/vicsanusi/ BGL socials: www.instagram.com/blackgalslivin/ + twitter.com/blackgalslivin/ Tik Tok: @blackgalslivin Chat to us using the hashtag #blackgalslivin⠀ Artwork by @thecamru Learn more about your ad choices. Visit podcastchoices.com/adchoices

Welcome to the Planet MicroCap Podcast's Due Diligence series. I'm your host, Robert Kraft. My guest today is Dan Goldberger, CEO of electroCore (NASDAQ: ECOR). electroCore is a commercial-stage neuromodulation company developing a suite of non-invasive vagus nerve stimulation devices—delivering a two-minute therapy session designed to rebalance the autonomic nervous system. Built around its nVNS platform, the company operates across three channels: prescription medical devices for headache and migraine, the fast-growing Truvaga direct-to-consumer wellness brand, and a specialized military and government division built around its ruggedized tac-stim product.   Founded in 2006 as a non-invasive alternative to implanted vagus nerve stimulators, electroCore has evolved into a multi-indication business with seven FDA authorizations for headache, serving major customers like the U.S. Department of Veterans Affairs and the UK's National Health Service. I invited Dan to the show to discuss all of this, as well as: How nVNS platform works and the science behind vagus nerve modulation electroCore's evolution from implanted alternatives to multi-channel neuromodulation The prescription business model across the VA, NHS, and managed care Truvaga's growth in the wellness market and why awareness is the primary competitor The tac-stim military program and its role as a meaningful revenue stream Strategic priorities heading into 2026—profitability, capital allocation, and commercial execution Challenges around insurance coverage and overcoming the “chicken and egg” problem The path toward becoming a $150–200 million business and the long-term vision for the platform For more information about electroCore, please visit: https://www.electrocore.com/ This podcast was recorded and is being made available by SNN, Inc. (together with its affiliates and its and their employees, “SNN”) solely for informational purposes. SNN is not providing or undertaking to provide any financial, economic, legal, accounting, tax, or other advice in or by virtue of this podcast. The information, statements, comments, views, and opinions provided in this podcast are general in nature, and such information, statements, comments, views, and opinions, and the viewing of/listening to this podcast are not intended to be and should not be construed as the provision of investment advice by SNN. The information, statements, comments, views, and opinions expressed in this podcast do not constitute and should not be construed as an offer to buy or sell any securities or to make or consider any investment or other course of action. The information, statements, comments, views, and opinions expressed in this podcast (including by guest speakers who are not officers, employees, or agents of SNN) are not necessarily those of SNN and may not be current. Reference to any specific third-party entity, product, service, materials, or content does not constitute an endorsement or recommendation by the SNN. SNN assumes no responsibility or liability for the accuracy or completeness of the content contained in third party materials or on third party sites referenced in this podcast or the compliance with applicable laws of such materials and/or links referenced herein. The views expressed by guest speakers are their own and their appearance on this podcast does not imply an endorsement of them or any entity they represent. SNN does not make any representation or warranty as to the accuracy or completeness of any of the information, statements, comments, views, or opinions contained in this podcast, which may include forward-looking statements where actual results may differ materially. SNN does not undertake any obligation whatsoever to provide any form of update, amendment, change, or correction to any of the information, statements, comments, views or opinions set forth in this podcast. SNN EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE, THIS PODCAST OR THE INFORMATION PRESENTED IN THIS PODCAST. By accessing this podcast, the listener acknowledges that the entire contents and design of this podcast, are the property of SNN, or used by SNN with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this podcast may save and use information contained in the podcast only for personal or other non-commercial educational purposes. No other use, including without limitation, reproduction, retransmission, or editing of this podcast may be made without the prior written consent of SNN.

Dr Rachel Clarke is a palliative care doctor and author, who became widely known for her writing on the challenges facing the NHS from the frontline of the Covid-19 pandemic. Since then she has also written a book, The Story of a Heart which was awarded the 2025 Women's Prize for Non-Fiction which tells the profoundly moving story of a heart transplant, and how one child saved the life of another. In November 2025 Clarke came to Intelligence Squared alongside actor, comedian and writer Rob Delaney to discuss this unforgettable story and what it tells us about compassion, family, medical innovation and the future of the national health service. --- This is the first instalment of a two-part episode. If you'd like to become a Member and get access to all our full ad free conversations, plus all of our Members-only content, just visit intelligencesquared.com/membership to find out more. For £4.99 per month you'll also receive: - Full-length and ad-free Intelligence Squared episodes, wherever you get your podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series - 15% discount on livestreams and in-person tickets for all Intelligence Squared events  ...  Or Subscribe on Apple for £4.99: - Full-length and ad-free Intelligence Squared podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series … Already a subscriber? Thank you for supporting our mission to foster honest debate and compelling conversations! Visit intelligencesquared.com to explore all your benefits including ad-free podcasts, exclusive bonus content and early access. … Subscribe to our newsletter here to hear about our latest events, discounts and much more. https://www.intelligencesquared.com/newsletter-signup/ Learn more about your ad choices. Visit podcastchoices.com/adchoices

https://www.youtube.com/watch?v=f54KzxOrRYM Premiered on 8 Dec 2025 The International Holocaust Remembrance Alliance is an organisation whose chief aim is to disseminate its 'working definition' of Antisemitism among the nations and institutions of the world. It was first adopted by Theresa May on behalf of the British Conservative (Tory) party in December 2016, but also on behalf of the British Nation. There has been no consultation about this. Nicola Sturgeon led the SNP and Scotland to accept it. Jeremy Corbyn led the Labour Party to adopt it while leader. After him Plaid Cymru, the Greens, the Liberals and every mainstream party of British imperialism has accepted and adopted it. THE definition has been pushed onto schools, universities, the police forces of the UK and now has been forced onto the NHS and all of its institutions in November 2025 by none other than the arch-ZIonist Wes Streeting, currently Labour Party's Health Secretary. It is a dangerous definition because it seeks to brand all criticism of Israel as 'racism' (antisemitism). By doing so it will outlaw all real criticism of Israel's genocide, all support for the freedom struggle of the oppressed in Palestine and by extension elsewhere. It is a means of Political policing and political repression - with very real economic consequences for those accused - by employers, the Labour Party apparatchiks and zionist activists - of "antisemitic" support for Palestine and criticism of Israel. Dr Ranjeet Brar - himself the serial victim of this legislation, definition and action - explains point by point, what is wrong with the IHRA definition, and why a rigorous campaign against it is needed throughout British society, including but not limited to the NHS, to defend basic political liberty and freedom of speech for the whole of the British working class. An essential tool for education and the campaign - please watch it in full and spread it widely. Subscribe! Donate! Join us in building a bright future for humanity! www.thecommunists.org www.lalkar.org www.redyouth.org Telegram: t.me/thecommunists Twitter: twitter.com/cpgbml Soundcloud: @proletarianradio Rumble: rumble.com/c/theCommunists Odysee: odysee.com/@proletariantv:2 Facebook: www.facebook.com/cpgbml Online Shop: https://shop.thecommunists.org/ Education Program: Each one teach one! www.londonworker.org/education-programme/ Join the struggle www.thecommunists.org/join/ Donate: www.thecommunists.org/donate/

What exactly is 'phantom pain' and how does it work? Hannah and Dara investigate a medical phenomenon that's been known about for centuries but is often misunderstood; and involves masses of unanswered questions.The condition 'phantom pain' is when someone gets a sensation of pain that feels like it's coming from a part of their body that's no longer there - so that could be an amputated limb, or perhaps something that has been removed, such as a tooth or an organ. It's thought to be caused by how the brain and body process pain and physical awareness, but there's still debate around what exactly is going on neurologically.Researchers around the world are looking into the condition; in the meantime, people who experience phantom pain - like today's studio guest Lynn - often have to try out a range of treatments, to find out what combination works best for them. But as the team discover, pain is deeply subjective - and in this case, there is really no 'right answer'...Contributors: - Tamar Makin, Professor of Cognitive Neuroscience at the MRC Cognition and Brain Sciences Unit at the University of Cambridge, where she leads the Plasticity Lab; - Lynn Williams, a qualified therapist and upper limb amputee who volunteered as a subject for one of Tamar's research programmes; - Carlos Roldan, Associate Professor in the Department of Pain Medicine at the University of Texas MD Anderson Cancer Center; - Keren Fisher, a Consultant Clinical Psychologist who's worked in the NHS for more than four decades; largely in pain management at the Royal National Orthopaedic Hospital.Producers: Emily Bird & Lucy Taylor Executive Producer: Alexandra FeachemA BBC Studios Audio Production

Wrapping up the stories of the week… Alex von Tunzelmann is joined by Jonn Elledge to examine the global response to the antisemitic Bondi Beach shooting and ask whether it signals a wider rise in the threat of terror attacks. Plus, how will resident doctor strikes affect the NHS as the flu wave intensifies? Jonn tries to work out if the unexpected drop in inflation is good or bad news for Rachel Reeves and crowns his winner and loser of the week.

Resident doctors make up about half of all NHS doctors so NHS leaders are anxious about how the service will cope.Host: Casey MagloireWriter & Producer: Amalie SortlandEpisode Photography: Joe MeeExecutive producer: Rebecca Moore Hosted on Acast. See acast.com/privacy for more information.

What happens when a class clown from Monaghan builds one of the most quietly impactful healthtech companies in Europe - and then takes on the U.S. healthcare system? In this year-end episode of The Shot of Digital Health Therapy, we sat down with Neill Dunwoody

The NHS is warning of an unprecedented flu season - we check what the numbers say.Is there really a mass exodus of Brits leaving the UK due to Labour tax policies? We look at the latest emigration figures.We take a look at the prison service's curious habit of letting prisoners out early – or keeping them in for too long - is there a trend?Plus - why the US economy can't grow at 25 percent a year.Presenter: Tim Harford Reporter: Nathan Gower Producers: Charlotte McDonald, Katie Solleveld, Lizzy McNeill and Tom Colls. Production co-ordinator: Maria Ogundele Sound mix: Gareth Jones Editor: Richard Vadon

Resident doctors in England have begun five days of strike action after rejecting the government's latest offer to resolve a long-running dispute over pay and jobs. The health secretary, Wes Streeting, met the British Medical Association on Tuesday in a final attempt to reach an agreement, but they failed to agree a deal. It means that resident doctors – formerly known as junior doctors – will remain on strike until 7am on Monday. Lucy Hough talks to the Guardian's health policy editor, Denis Campbell – watch on YouTube. Help support our independent journalism at theguardian.com/infocus

Thousands of resident doctors are going on strike today despite a flu outbreak which is already putting hospitals under pressure. The NHS says it's facing a “worst-case scenario” in the run up to Christmas, so will the health service be able to cope?This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: http://thetimes.com/thestoryGuest: Eleanor Hayward, health editor, The Times.Joshua Bratt, photojournalist who had a severe bout of flu.Host: Jane Mulkerrins.Producer: Shabnam Grewal, Edward DrummondRead more: What the new superflu feels like: a drill inside my headWes Streeting: NHS risks collapse from strikes threat and ‘superflu'Clips: Times Radio, LBC, Sky News.Photo: Getty Images.Get in touch: thestory@thetimes.comThis podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here. Hosted on Acast. See acast.com/privacy for more information.

Across biotech labs, researchers swim in oceans of process data: sensor streams, run records, engineering logs, and still, crucial decisions get stuck in spreadsheets or scribbled into fading notebooks. The challenge isn't having enough information, it's knowing which actions actually move the needle in cell culture productivity, process stability, and faster timelines.This episode, David Brühlmann brings on Ilya Burkov, Global Head of Healthcare and Life Sciences Growth at Nebius AI. With a career spanning NHS medicine, regenerative research, and cloud infrastructure, Ilya Burkov has lived the leap from microscope to server room. He's seen firsthand how digital twins, autonomous experimentation, and cloud-first strategies are shifting the way biologics are developed and scaled.Topics discussed:Shifting from experimental-based to computational bioprocess development, and the evolving role of human expertise vs. AI (02:48)Ilya Burkov's journey from medicine and orthopedics to AI and cloud infrastructure (04:15)Solving data silos and making real-time decisions with digital twins and automated analytics (06:36)The impact of AI-driven lab automation and robotics on drug discovery timelines (08:51)Using AI to accelerate cell line selection, cloning, and protein sequence optimization (10:12)Why wet lab experimentation is still essential, and how predictive modelling can reduce failure rates (11:15)Reducing costs and accelerating development by leveraging AI in process screening and optimization (12:32)Strategies for smaller companies to effectively store and manage bioprocess data, including practical advice on cloud adoption and security (14:30)Application of AI and digital twins in scale-up processes, and connecting diverse data types like CFD simulations and process data (17:18)The ongoing need for human expertise in interpreting and qualifying data, even as machine learning advances (19:09)Wondering how to stop your own data from gathering dust? This episode unpacks practical strategies for storing and leveraging your experimental records - whether you're in a major pharma or a small startup with limited tech resources.Connect with Ilya Burkov:LinkedIn: www.linkedin.com/in/ilyaburkovContact email: ilya.burkov@nebius.comNebius: www.nebius.comIf this topic grabbed you, you'll love these related episodes focusing on advanced modeling, continuous manufacturing, and Digital TwinsEpisodes 213 - 214: From Developability to Formulation: How In Silico Methods Predict Stability Issues Before the Lab with Giuseppe LicariEpisodes 85 - 86: Bioprocess 4.0: Integrated Continuous Biomanufacturing with Massimo MorbidelliEpisodes 05 - 06: Hybrid Modeling: The Key to Smarter Bioprocessing with Michael SokolovEpisode 153 - 154: The Future of Bioprocessing: Industry 4.0, Digital Twins, and Continuous Manufacturing Strategies with Tiago MatosEpisodes 173 - 174: Mastering Hybrid Model Digital Twins: From Lab Scale to Commercial Bioprocessing with Krist GernaeyNext step:Need fast CMC guidance? → Get rapid CMC decision support hereSupport the show

The US president is suing the BBC for a whopping $10bn, and Camilla and Tim are referred to in the lawsuit.Donald Trump alleges he was defamed by Panorama and Newsnight's misleading editing of his speech ahead of the Jan 6 2021 Capitol riot.Former BBC legal eagle Joshua Rozenberg explains the merits of settling or fighting Trump's suit to the bitter end.Plus, resident doctors are going on strike just as the NHS faces a tidal wave of severe flu cases. We hear how the union has been captured by militant Leftists, and ask if medics should be banned from striking altogether.We want to hear from you! Email us at thedailyt@telegraph.co.uk or find @dailytpodcast on TikTok, Instagram and X► Sign up to our most popular newsletter, From the Editor. Look forward to receiving free-thinking comment and the day's biggest stories, every morning. telegraph.co.uk/fromtheeditorProducer: Lilian FawcettSenior Producer: David LeveneExecutive Producer: Louisa WellsVideo Producers: Will WaltersStudio Operator: Meghan SearleSocial Producer: Nada AggourEditor: Camilla Tominey Hosted on Acast. See acast.com/privacy for more information.

In this episode, I speak with Dr Anna Colton, a clinical psychologist who specialises in adolescence and eating disorders. We explore the rise of eating disorders, the impact of the pandemic, and how social media and diet culture shape young people's relationship with food and their bodies. The conversation offers practical, compassionate guidance for parents and caregivers on talking with children and teens about nutrition, body image, and healthy eating patterns. Anna is the author of How to Talk to Children About Food, and shares actionable strategies for conversations at home, signs to watch for, and when to seek professional help.   Key takeaways - Eating disorders are increasing, with the pandemic cited as a major contributing factor. Social and cultural pressures around weight have intensified with the introduction of weight-loss medications and pervasive diet messaging on social media. A large portion of nutrition guidance consumed by young people comes from platforms like Instagram and TikTok, where most content is not accurate. - Adolescence involves two key developmental tasks: separation from caregivers and individuation (forming a sense of self). COVID-era restrictions disrupted these processes, which, alongside heightened emotions and risk messaging, created an opportunity for disordered eating to flourish. - Language matters when talking about food. Be specific and neutral rather than labeling foods as “healthy” or “unhealthy.” Avoid fear-based or punitive messaging (e.g., “that will make you fat”). Emphasize balance, variety, and the overall pattern of the diet rather than single meals. - Create a healthy home food environment. Allow for a range of foods at home, avoid using food as a reward or punishment, and be cautious about restricting foods. This supports self-regulation and reduces the likelihood of binge-eating cycles driven by deprivation. - Focus on body function and acceptance, not appearance. There are billions of unique bodies, and variation is normal. Encourage body acceptance and appreciation for what the body does (movement, health, energy) rather than how it looks. It's realistic to acknowledge that not everyone feels positive about their body every day. - Support for puberty and body changes. Hormonal fluctuations and evolving bodies during adolescence can be unsettling. Discuss differences in energy needs, portions, and activity levels openly, and acknowledge that it's normal for bodies to change at different rates. - Handling trends with curiosity. Teens may be drawn to gym culture and protein supplements. It's useful to explore the evidence together, rather than dismissing interest. Encourage evidence-based choices and avoid pressuring or shaming. - Early signs of potential eating disorders. Watch for significant changes in eating patterns (skipping meals, cutting out whole food groups), increased anxiety around meals, extreme weight changes, and irregular periods in girls. If you notice these signs, approach with curiosity and seek help promptly. - Initial steps if you're concerned. Start with careful observation over a short period, then have a non-judgmental conversation. If concerns persist, consult a GP for baseline checks (weight, height, bloods) and consider seeing a psychologist or ED specialist. Early intervention is preferable to waiting for illness to become severe. - Treatment principles and parental roles. In anorexia, parents may need to support structured eating as part of recovery. In binge patterns, reducing restriction helps, since hunger drives cravings. Special situations like ARFID require expert assessment and tailored exposure-based strategies. The NHS and ED services are under-resourced, so timely engagement with healthcare providers is crucial. - When to seek specialist help. If concerns persist, especially with weight changes, food avoidance, or distress around eating, connect with a healthcare professional early. A qualified psychologist or dietitian with ED experience can offer targeted guidance and support.   Resources    Anna Colton's book How to Talk to Children About Food is a practical primer for parents.  You can follow her on https://www.instagram.com/drannacolton  search for The Food Psychologist on TikTok and her LinkedIn is https://www.linkedin.com/in/dr-anna-colton-79975521/  for evidence-based insights and ongoing discussions about eating, weight, and body image. If you enjoy the podcast please help us grow by sharing this episode, or writing a review. You can also find me at http://www.thetripleshift.org   connect with me at https://www.linkedin.com/in/emmacthomas/   follow along on Instagram at https://www.instagram.com/middlingalong_podcast/  or subscribe to my Substack at https://middlingalong.substack.com/   

The "evil" mass shooting at Bondi Beach was the latest in a rising number of antisemitic attacks.16 people died in the attack in Sydney, Australia. They were Jews who had gathered to celebrate the first night of Chanukah. Among them, a holocaust survivor and a ten-year old girl.Antisemitic attacks are on the rise. In this year to September, Australia recorded 1654 anti-semitic incidents. That's three times higher than any year before the war in Gaza.Here in the UK, Jews faced over 1,500 attacks in the first half of 2025, according to data from the Community Security Trust. That's the second-highest total in the first half of any year on record, and includes the terrorist attack on a synagogue in Manchester in which two people died. In July, a report authored by Lord John Mann & Penny Mordaunt found “widespread failures to address anti-jewish discrimination in NHS, education, arts and policing”. Oli Dugmore is joined by Rachel Cunliffe and Hannah Barnes to ask: are Jews safe?READ: The Bondi Beach shooting was an attack on Jews.SAVE £££ THIS CHRISTMAS:⭐️ Gift big ideas, bold politics, and proper journalism from just £2LISTEN AD-FREE:

STARMER: Stand Down Now to Save the UK | General Election NOW  #Starmer #UKPolitics #LabourParty #StarmerOUT #GeneralElection #JonGaunt #Live Keir  Starmer's end-of-year review has exposed a brutal truth: he may be Prime Minister, but he is not in control.  Approval ratings in the gutter. A Labour Party briefing against its own leader. MPs openly restless. And now, heading into Christmas, doctors preparing to strike, pushing the NHS deeper into chaos. Starmer promised seriousness, authority and competence.  What the country is seeing instead is drift, division and weakness. Borders still not secure. Small boats still crossing. A so-called "one-in, one-out" deal with France that sounds tough but delivers little. Leadership pledges quietly abandoned. Principles rewritten when they become inconvenient.  Even Starmer himself admitted today that his leadership is under strain — a staggering admission from a man sold as the "safe pair of hands".  This is leadership by press release. Government without grip. A Prime Minister in office but not in control. Everything he touches seems to go wrong — the reverse Midas touch. And now his own MPs are circling, because they know what the public already feels: this government is running on empty.  Britain cannot afford paralysis, party games and permanent crisis. If Starmer cannot lead, he should stand down. If this government cannot govern, the people must decide. General Election NOW.  

In this episode of Mark and Pete, we take a clear-eyed look at three stories that reveal how badly modern Britain and the wider West now struggle with value, authority, and fear.We begin with the theft of more than 600 artefacts from a Bristol museum. Individually, the items are of little monetary worth, but collectively they represent something far more important: history, memory, and inheritance. We ask what motivates a crime like this, what the thieves can possibly do with such objects, and what it says about a culture that no longer understands the difference between price and worth.Next, we turn to Australia's decision to ban children from using social media. The policy lasted about five minutes before children worked around it. We explore why governments repeatedly try to legislate formation, why this always fails, and why parenting, presence, and moral training cannot be outsourced to the state or to technology.Finally, we look at the latest flu outbreak and the familiar NHS response: emergency language, crisis messaging, and calls for public alarm. We discuss the difference between prudence and panic, why institutions now rely on fear to function, and how Christians are called to respond to illness and risk with steadiness rather than hysteria.We reflect on Proverbs 22:6 — “Train up a child in the way he should go” — and consider what happens when societies stop training, start panicking, and forget what really matters.

​​Today, the Prime Minister Keir Starmer has written in the Guardian Newspaper urging members of the British Medical Association to rethink planned strikes. ​​ ​​Possible strikes coincide with flu-related illnesses and hospitalisations at a higher rate than usual for this time of year, which have led to worries that a strike would lead to problems for the NHS. ​​ ​​Also, Laura has spoken to the new chair of the Equality and Human Rights Commission, Dr Mary-Ann Stephenson. Since the Supreme Court ruling over the definition of a woman in April they have been working on new guidance on who can access single-sex spaces. So how might the guidance be implemented? ​​ ​​You can now listen to Newscast on a smart speaker. If you want to listen, just say "Ask BBC Sounds to play Newscast”. It works on most smart speakers. ​​ ​​You can join our Newscast online community here: https://bbc.in/newscastdiscord ​​ ​​Get in touch with Newscast by emailing newscast@bbc.co.uk or send us a WhatsApp on +44 0330 123 9480. ​​ ​​New episodes released every day. If you're in the UK, for more News and Current Affairs podcasts from the BBC, listen on BBC Sounds: https://bbc.in/4guXgXd ​​ ​​Newscast brings you daily analysis of the latest political news stories from the BBC. The presenters were Laura Kuenssberg and Paddy O'Connell It was made by Chris Flynn with Rufus Gray. The social producer was Joe Wilkinson. The technical producer was Michael Regaard. The weekend series producer is Chris Flynn. The assistant editor is Chris Gray. The senior news editor is Sam Bonham.

Baroness Amos, who was appointed by the Health Secretary to lead an independent rapid investigation into NHS maternity and neonatal care in England, has said nothing prepared her for the scale of 'unacceptable care' that women and families have received. Presenter Krupa Padhy is joined by the BBC's Social Affairs correspondent Michael Buchanan and Theo Clarke, former Conservative MP who also chaired the UK Birth Trauma Inquiry and hosts the podcast, Breaking the Taboo, to discuss the review and what comes next.Wages for housework was a feminist mantra in the West in the 1970s – feminist campaigners arguing for recognition of the economic value of domestic labour. The debate has been revived in India over the last decade with an estimated 118 million women across 12 states now receiving unconditional cash transfers from their governments. Devina Gupta, a reporter based in Delhi, and Professor Prabha Kotiswaran from King's College in London unpick the impact of ‘wages for housework' on women's lives and the Indian economy.When Kaitlin Lawrence was just 22 years old, she collapsed whilst playing netball for the then Super League side Surrey Storm. She was eventually diagnosed with arrhythmogenic cardiomyopathy (ACM), a genetic condition she never knew she had. Following this, she was forced to give up her dream of playing professionally for Scotland and has gone on to successfully campaign to get cardiac screening introduced in the Netball Super League next season. She tells Anita her story. They were joined by Presenter Gabby Logan, whose younger brother died suddenly at the age of 15 years old from an undiagnosed heart condition. Hypertrophic cardiomyopathy.A new report highlights the crucial role of strength training and exercise for people on weight loss drugs. Data gathered by fitness professionals, Les Mills and the not-for-profit industry body, ukactive, shows the impact of weight loss drugs on skeletal muscle mass. Their report says that 20-50% of weight loss is lean body mass, which poses significant health risks such as frailty, disability, reduced metabolism, and increased mortality. Physiotherapist Lucy McDonald and Dr Sarah Jarvis join Krupa to discuss the importance of strength training to mitigate muscle loss.Presenter: Anita Rani Producer: Dianne McGregor

Hey everyone and welcome back to another episode of Unseen Incidents! We're getting into the Salah drama this week, as the Egyptian put his Anfield career in the sarcophagus with an explosive interview. What led to his outburst? Does he have a point? Is there any way back? And how can Liverpool benefit from the situation? Then we open up the Burn Book, this week chatting Winter Wonderland, the NHS, and performative behaviour. Check out Patreon.com/patrickvs for access to more episodes! Stay toxic!

This episode was originally released November 10th for Death Panel patrons and is being unlocked today for the first time. To support the show and help make episodes like this one possible, become a patron at www.patreon.com/deathpanelpod National Health Service (NHS) evolved under the neoliberal turn and what the recently released NHS 10 year plan tells us about the future of health struggle not just in Britain but internationally, promising as it does to make the NHS “the most AI enabled care system in the world” and to transform it “into an engine for economic growth, rather than a beneficiary of it.” Find Red Medicine here: https://linktr.ee/redmedicine.xyz Show links: We're testing out a new Bookshop.org page (still under construction), where you can find books by past guests and book recommendations from the hosts. Find it here: bookshop.org/shop/deathpanel Get Health Communism here: bookshop.org/a/118130/9781839765179 Find Tracy's book Abolish Rent here: bookshop.org/a/118130/9798888902523 Find Jules' latest book, A Short History of Trans Misogyny, here: bookshop.org/a/118130/9781804291603 Outro by Time Wharp: timewharp.bandcamp.com/track/tezeta

In this episode of Ask Kati Anything, we dive deep into the complex and often unspoken corners of mental health recovery. We explore the psychology behind why some individuals experience persistent suicidal thoughts without the intent to act and discuss strategies for navigating friendships that inadvertently trigger eating disorder relapses or competition. I also open up about the ethics of plastic surgery when dealing with body dysmorphia , the "push-pull" dynamic in therapy often associated with BPD and attachment wounds , and share my professional perspective on gender-affirming care and the importance of therapeutic support. Finally, we analyze a shocking listener story about a therapist allowing a date in their office, breaking down the major red flags of blurred boundaries. My new book is in stores now! Why Do I Keep Doing This? → https://geni.us/XoyLSQ Get Yours For The Holiday - If you've ever felt stuck, this book is for you. I'd be so grateful for your support. 00:00 – Intro 00:19 – Why do I have suicidal thoughts but can't act on them?  06:00 – When a friend's passion triggers your Eating Disorder relapse  12:21 – Navigating Anorexia recovery when treatment is denied (NHS & Weight Stigma)  20:06 – CrowdHealth message 21:53 – Plastic Surgery: Confidence booster or Body Dysmorphia?  27:35 – Envisioning suicidal scenarios & struggles with Lithium medication  33:02 – Why do I push my therapist away? (Fear of Abandonment & BPD)  36:36 – OneSkin message 38:13 – AuraFrames message 43:44 – My honest opinion on Gender Affirming Care & the "Affirm First" approach  52:37 – Red Flags: My therapist let me have a date in her office?!  Shopping with our sponsors helps support the show and allows us to continue bringing you these important conversations about mental health. Please check out this week's special offers: • CrowdHealth: get started today for $99 for your first three months using code ASKKATI at https://www.joincrowdhealth.com/ • OneSkin: For a limited time, try OneSkin for 15% off using code KATI at https://www.oneskin.co/Kati • Aura Frames: Exclusive $35 off Carver Mat at https://on.auraframes.com/KATI Promo Code KATI  Ask Kati Anything ep. 292 | Your mental health podcast, with Kati Morton, LMFT  MAIN YOUTUBE CHANNEL www.youtube.com/@Katimorton  #podcast #psychology #katimorton  MY BOOKS Why Do I Keep Doing This? https://geni.us/XoyLSQ  Traumatized https://geni.us/Bfak0j  Are u ok? https://geni.us/sva4iUY  ONLINE THERAPY (enjoy 10% off your first month) While I do not currently offer online therapy, BetterHelp can connect you with a licensed, online therapist: https://betterhelp.com/kati  PARTNERSHIPS Nick Freeman | nick@biglittlemedia.co  Disclaimer: The information provided in this video is for educational and informational purposes only and is not intended as medical or mental health advice. It should not be used to diagnose or treat any health problem or disease. Always consult with a qualified healthcare professional for diagnosis and treatment. Viewing this content does not establish a therapist-client relationship. Learn more about your ad choices. Visit megaphone.fm/adchoices

Who does our data belong to? In this episode, Carl Miller speaks to NYT magazine journalist and author Michael Steinberger about Alex Karp, Palantir and the rise of the surveillance state. Founded in 2003, Palantir is widely regarded as the most interesting company in Silicon Valley – as well as its most controversial. It aided the US government in the war on terrorism and is now used by the CIA, the NHS, the US military and corporate giants like Airbus and BP. But its billionaire CEO, Alex Karp, is not like the other CEOs. In The Philosopher in the Valley, Michael Steinberger, who had unprecedented access to Karp during the writing of this biography, offers a detailed account of Karp's singular approach to leadership and how he is preparing Palantir, and the world, for a future dominated by technological power.  Michael Steinberger is a longtime journalist who writes primarily for The New York Times Magazine. He has written cover stories for the magazine about Joe Biden, George Soros, and Roger Federer. Before becoming a journalist, Steinberger spent several years working on Wall Street. He is the author of Au Revoir to All That: Food, Wine, and the End of France and The Wine Savant: A Guide to the New Wine Culture.  If you'd like to become a Member and get access to all our full conversations, plus all of our Members-only content, just visit intelligencesquared.com/membership to find out more. For £4.99 per month you'll also receive: - Full-length and ad-free Intelligence Squared episodes, wherever you get your podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series - 15% discount on livestreams and in-person tickets for all Intelligence Squared events  ...  Or Subscribe on Apple for £4.99: - Full-length and ad-free Intelligence Squared podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series … Already a subscriber? Thank you for supporting our mission to foster honest debate and compelling conversations! Visit intelligencesquared.com to explore all your benefits including ad-free podcasts, exclusive bonus content and early access. … Subscribe to our newsletter here to hear about our latest events, discounts and much more. https://www.intelligencesquared.com/newsletter-signup/ Learn more about your ad choices. Visit podcastchoices.com/adchoices Learn more about your ad choices. Visit podcastchoices.com/adchoices